Skip to content
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
Kidney cancer
Dr. Robert J. Motzer on the survival benefit of pembrolizumab / lenvatinib in the RCC front line
Intracranial Response Achieved by Cabozantinib in mRCC | Targeted oncology
Cabozantinib induces intracranial / extracranial responses in metastatic RCC | Targeted oncology
ASCO GU: Merck, Eisai turn up the heat in kidney cancer with Keytruda-Lenvima survival data
A study examining the effect of surgical delay for renal cell carcinoma during COVID-19 pandemic
Biomarkers may help to discriminate cancer-related kidney injuries from other causes
